Rosiglitazone maleate

This classification denotes a vasodilator agent, fibrinolytic agent, and hypoglycemic agent with the molecular formula C18H19N3O3S.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KX2339DP44, chemically known as 2,4-thiazolidinedione, 5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)- but more generally known as rosiglitazone maleate, which bears US NIH Compound Identifier 77999. European Medicines Agency schedules Rosiglitazone maleate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04274MIG. Most nations, for tariff and trade purposes, schedule rosiglitazone maleate under HS 29341000 and SITC 51579. As of Q4 2014, ROSIGLITAZONE MALEATE remains US FDA's Preferred Term for this commodity. Rosiglitazone maleate bears US NLM identifiers UMLS ID C0795660 and NCI Concept Code C2583. SMILES: CN(CCOC1CCC(CC1)CC2C(=O)NC(=O)S2)C3CCCCN3.C(=C\C(=O)O)\C(=O)O.